CD3e-immunotoxin spares CD62L lo Tregs and reshapes organ-specific T-cell composition by preferentially depleting CD3e hi T cells
Preprint
Abstract
CD3-epsilon(CD3e) immunotoxins (IT), a promising precision reagent for various clinical conditions requiring effective depletion of T cells, often shows limited treatment efficacy for largely unknown reasons. Tissue-resident T cells that persist in peripheral tissues have been shown to play pivotal roles in local and systemic immunity, as well as transplant rejection, autoimmunity and cancers. The impact of CD3e-IT treatment on these local cells, however, remains poorly understood. Here, using a new murine testing model, we demonstrate a substantial enrichment of tissue-resident Foxp3+ Tregs following CD3e-IT treatment. Differential surface expression of CD3e among T-cell subsets appears to be a main driver of Treg enrichment in CD3e-IT treatment. The surviving Tregs in CD3e-IT-treated mice were mostly the CD3e dim CD62L lo effector phenotype, but the levels of this phenotype markedly varied among different lymphoid and nonlymphoid organs. We also found notable variations in surface CD3e levels among tissue-resident T cells of different organs, and these variations drive CD3e-IT to uniquely reshape T-cell compositions in local organs. The functions of organs and anatomic locations (lymph nodes) also affected the efficacy of CD3e-IT. The multi-organ pharmacodynamics of CD3e-IT and potential treatment resistance mechanisms identified in this study may generate new opportunities to further improve this promising treatment.Keywords
All Related Versions
- Published version: Frontiers in Immunology, 13, 1011190.
This publication has 102 references indexed in Scilit:
- Tolerance to Vascularized Composite Allografts in Canine Mixed Hematopoietic ChimerasTransplantation, 2011
- Development of a Diphtheria Toxin Based Antiporcine CD3 Recombinant ImmunotoxinBioconjugate Chemistry, 2011
- Foxp3+ follicular regulatory T cells control the germinal center responseNature Medicine, 2011
- Phenotypical and functional specialization of FOXP3+ regulatory T cellsNature Reviews Immunology, 2011
- Partial and transient modulation of the CD3–T‐cell receptor complex, elicited by low‐dose regimens of monoclonal anti‐CD3, is sufficient to induce disease remission in non‐obese diabetic miceImmunology, 2010
- A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicityBlood, 2009
- Regulatory T Cells Sequentially Migrate from Inflamed Tissues to Draining Lymph Nodes to Suppress the Alloimmune ResponseImmunity, 2009
- Antigen-specific peripheral shaping of the natural regulatory T cell populationJournal of Experimental Medicine, 2008
- Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytesNature Medicine, 2007
- CCR7 is required for the in vivo function of CD4+ CD25+ regulatory T cellsJournal of Experimental Medicine, 2007